Furthermore, one study found that metformin impaired learning and memory in older Alzheimer’s disease (AD)-model mice and increased amyloid pathology and tau protein phosphorylation, directly contradicting its purported benefits in Alzheimer’s disease models [176]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.